{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T13:56:28Z","timestamp":1794837388027,"version":"4.9.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":121,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["SFB 54"],"award-info":[{"award-number":["SFB 54"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004061","name":"Oesterreichische Nationalbank","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"NIH Clinical Center","doi-asserted-by":"publisher","award":["R01DK095024"],"award-info":[{"award-number":["R01DK095024"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1111\/jth.15508","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T16:33:19Z","timestamp":1629563599000},"page":"2984-2996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Anticoagulation use and the risk of stroke and major bleeding in patients on hemodialysis: From the VIVALDI, a population\u2010based prospective cohort study"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6183-3685","authenticated-orcid":false,"given":"Oliver","family":"K\u00f6nigsbr\u00fcgge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aljoscha","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Schmaldienst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Klauser\u2010Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Auinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Kletzmayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Hecking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang C.","family":"Winkelmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Pabinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"S\u00e4emann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2607-9717","authenticated-orcid":false,"given":"Cihan","family":"Ay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.15508_bb0010","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/eurheartj\/ehu139","article-title":"Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study","volume":"36","author":"Friberg","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1111\/jth.15508_bb0015","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1523-1755.2003.00101.x","article-title":"Elevated risk of stroke among patients with end\u2010stage renal disease","volume":"64","author":"Seliger","year":"2003","journal-title":"Kidney Int"},{"key":"10.1111\/jth.15508_bb0020","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/CIRCULATIONAHA.108.816082","article-title":"Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study","volume":"119","author":"Go","year":"2009","journal-title":"Circulation"},{"key":"10.1111\/jth.15508_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169400","article-title":"Prevalence of atrial fibrillation and antithrombotic therapy in hemodialysis patients: cross\u2010sectional results of the Vienna InVestigation of AtriaL fibrillation and thromboembolism in patients on hemodialysis (VIVALDI)","volume":"12","author":"K\u00f6nigsbr\u00fcgge","year":"2017","journal-title":"PLoS One"},{"key":"10.1111\/jth.15508_bb0030","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15508_bb0035","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1681\/ASN.2015050535","article-title":"The risk of major hemorrhage with CKD","volume":"27","author":"Molnar","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/jth.15508_bb0040","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart R","volume":"74","author":"January","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.15508_bb0045","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"10.1111\/jth.15508_bb0050","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user\u2010friendly score (HAS\u2010BLED) to assess 1\u2010year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1111\/jth.15508_bb0055","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1093\/eurheartj\/ehy060","article-title":"Chronic kidney disease and arrhythmias: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"39","author":"Turakhia","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1111\/jth.15508_bb0060","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/rth2.12250","article-title":"Atrial fibrillation in patients with end\u2010stage renal disease on hemodialysis: magnitude of the problem and new approach to oral anticoagulation","volume":"3","author":"K\u00f6nigsbr\u00fcgge","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1111\/jth.15508_bb0065","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.jacc.2019.08.1031","article-title":"Anticoagulation in concomitant chronic kidney disease and atrial fibrillation: JACC review topic of the week","volume":"74","author":"Kumar","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.15508_bb0070","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report","volume":"154","author":"Lip","year":"2018","journal-title":"Chest"},{"key":"10.1111\/jth.15508_bb0075","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non\u2010major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non\u2010surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15508_bb0080","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15508_bb0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000046216","article-title":"Incidence of stroke among chronic hemodialysis patients with nonrheumatic atrial fibrillation","volume":"21","author":"Wiesholzer","year":"2001","journal-title":"Am J Nephrol"},{"key":"10.1111\/jth.15508_bb0090","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1053\/j.ajkd.2013.10.013","article-title":"Risk of stroke in long\u2010term dialysis patients compared with the general population","volume":"63","author":"Wang","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/jth.15508_bb0095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCULATIONAHA.115.018294","article-title":"Risks of death and stroke in patients undergoing hemodialysis with new\u2010onset atrial fibrillation: a competing\u2010risk analysis of a nationwide cohort","volume":"133","author":"Shih","year":"2016","journal-title":"Circulation"},{"key":"10.1111\/jth.15508_bb0100","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/ndt\/gfx301","article-title":"Risk profiles for acute health events after incident atrial fibrillation in patients with end\u2010stage renal disease on hemodialysis","volume":"33","author":"Airy","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/jth.15508_bb0105","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.hrthm.2014.06.021","article-title":"Incidence and prediction of ischemic stroke among atrial fibrillation patients with end\u2010stage renal disease requiring dialysis","volume":"11","author":"Chao","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1111\/jth.15508_bb0110","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/ki.2009.477","article-title":"Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy","volume":"77","author":"Wizemann","year":"2010","journal-title":"Kidney Int"},{"key":"10.1111\/jth.15508_bb0115","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1161\/CIRCULATIONAHA.113.004777","article-title":"Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis","volume":"129","author":"Shah","year":"2014","journal-title":"Circulation"},{"key":"10.1111\/jth.15508_bb0120","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/MNH.0b013e32835856fd","article-title":"Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks?","volume":"21","author":"Shen","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1111\/jth.15508_bb0125","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1681\/ASN.2009030319","article-title":"Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation","volume":"20","author":"Chan","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/jth.15508_bb0130","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease","volume":"367","author":"Olesen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15508_bb0135","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1161\/CIRCULATIONAHA.111.020982","article-title":"Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study","volume":"123","author":"Alonso","year":"2011","journal-title":"Circulation"},{"key":"10.1111\/jth.15508_bb0140","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/ki.2009.185","article-title":"Atrial fibrillation in incident dialysis patients","volume":"76","author":"Vazquez","year":"2009","journal-title":"Kidney Int"},{"key":"10.1111\/jth.15508_bb0145","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.108.783738","article-title":"Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis","volume":"118","author":"Shroff","year":"2008","journal-title":"Circulation"},{"key":"10.1111\/jth.15508_bb0150","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end\u2010stage renal disease: Impact on all\u2010cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/jth.15508_bb0155","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.ajkd.2011.10.041","article-title":"Effect of vitamin K2 supplementation on functional vitamin k deficiency in hemodialysis patients: randomized trial","volume":"59","author":"Westenfeld","year":"2012","journal-title":"Am J kidney Dis"},{"key":"10.1111\/jth.15508_bb0160","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.blre.2012.03.002","article-title":"Vascular calcification: the price to pay for anticoagulation therapy with vitamin K\u2010antagonists","volume":"26","author":"Chatrou","year":"2012","journal-title":"Blood Rev"},{"key":"10.1111\/jth.15508_bb0165","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1681\/ASN.2016060651","article-title":"Vitamin K \u2010 dependent carboxylation of matrix Gla protein influences the risk of calciphylaxis","volume":"28","author":"Nigwekar","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/jth.15508_bb0170","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1160\/TH16-10-0815","article-title":"Pharmacokinetics of tecarfarin and warfarin in patients with severe chronic kidney disease","volume":"117","author":"Albrecht","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15508_bb0175","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/j.ajkd.2007.06.017","article-title":"Warfarin anticoagulation in hemodialysis patients: a systematic review of bleeding rates","volume":"50","author":"Elliott","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/jth.15508_bb0180","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1053\/j.ajkd.2015.05.019","article-title":"Outcomes after warfarin initiation in a cohort of hemodialysis patients with newly diagnosed atrial fibrillation","volume":"66","author":"Shen","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/jth.15508_bb0185","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1378\/chest.15-1719","article-title":"Stroke, major bleeding, and mortality outcomes in warfarin users with atrial fibrillation and chronic kidney disease: a meta\u2010analysis of observational studies","volume":"149","author":"Dahal","year":"2016","journal-title":"Chest"},{"key":"10.1111\/jth.15508_bb0190","first-page":"1","article-title":"Association between use of warfarin for atrial fibrillation and outcomes among patients with end\u2010stage renal disease a systematic review and meta\u2010analysis","volume":"3","author":"Randhawa","year":"2020","journal-title":"JAMA Open"},{"key":"10.1111\/jth.15508_bb0195","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1681\/ASN.2019060579","article-title":"Multicenter randomized controlled trial of Vitamin K antagonist replacement by rivaroxaban with or without vitamin K2 in hemodialysis patients with atrial fibrillation: the Valkyrie study","volume":"31","author":"de Vriese","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/jth.15508_bb0200","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/CIRCULATIONAHA.114.014113","article-title":"Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis","volume":"131","author":"Chan","year":"2015","journal-title":"Circulation"},{"key":"10.1111\/jth.15508_bb0205","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.118.035418","article-title":"Outcomes associated with apixaban use in patients with end\u2010stage kidney disease and atrial fibrillation in the United States","volume":"128","author":"Siontis","year":"2018","journal-title":"Circulation"},{"key":"10.1111\/jth.15508_bb0210","first-page":"1078","article-title":"Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and severe kidney disease or undergoing hemodialysis","volume":"132","author":"Coleman","year":"2019","journal-title":"Am J Med Elsevier Inc"},{"key":"10.1111\/jth.15508_bb0215","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Identifer NCT02933697. Compare Apixaban and Vitamin\u2010K Antagonists in Patients With Atrial Fibrillation (AF) and End\u2010Stage Kidney Disease (ESKD) (AXADIA), 2016. Available from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02933697?term=AXADIA&draw=2&rank=1"},{"key":"10.1111\/jth.15508_bb0220","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Identifer NCT03987711. Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis (SAFE\u2010D), 2019. Available from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03987711?term=SAFE\u2010D&draw=2&rank=2"},{"key":"10.1111\/jth.15508_bb0225","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Identifier NCT02886962. Oral Anticoagulation in Haemodialysis Patients (AVKDIAL), 2016. Available from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02886962"},{"key":"10.1111\/jth.15508_bb0230","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Identifer NCT03862859. The Danish Warfarin\u2010Dialysis Study \u2010 Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis (DANWARD), 2019. Available from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03862859?term=DANWARD&draw=2&rank=1"},{"key":"10.1111\/jth.15508_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2020.02.011","article-title":"Antithrombotic agents for primary and secondary prevention of cardiovascular events in patients with end\u2010stage renal disease on chronic hemodialysis","volume":"298","author":"K\u00f6nigsbr\u00fcgge","year":"2020","journal-title":"Atherosclerosis"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15508","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15508","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622005438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622005438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15508","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:29:25Z","timestamp":1761535765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622005438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1538783622005438"],"URL":"https:\/\/doi.org\/10.1111\/jth.15508","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation use and the risk of stroke and major bleeding in patients on hemodialysis: From the VIVALDI, a population\u2010based prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}